By designating only one reference listed drug as the common to which all generic versions have to be revealed to get bioequivalent, FDA hopes in order to avoid feasible significant variations among generic drugs as well as their brand name counterpart. Quoted prices are for funds-paying customers and therefore are not valid with insurance plans.